Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Braz. arch. biol. technol ; 63: e20200087, 2020. tab, graf
Article in English | LILACS | ID: biblio-1132188

ABSTRACT

Abstract In the current study, nanocapsules (NC) formulations containing a co-load of clotrimazole (C), a highly prescribed antifungal drug, and diphenyl diselenide [(PhSe)2], an organoselenium compound with a promising scope of pharmacological actions, were prepared. Formulations were characterized as well as the potential toxicity, antioxidant action, and antifungal effect were assessed using in vitro techniques. The NCs were prepared employing Eudragit® RS 100 as polymeric wall and medium chain triglycerides or virgin coconut oil (CO) as core. All NC suspensions had pH around acid range, compound content close to theoretical value (1 mg/mL/drug), average diameter in nanometric range, positive values of zeta potential as well as high encapsulation efficacy and mucoadhesive property. Physicochemical stability was performed over a 30-day period and showed no modification in the aforementioned parameters to all samples. Preliminary screening of toxicological potential performed by the hen's egg test chorioallantoic membrane technique classified the formulations as non-irritant. The DPPH radical assay revealed that nanoencapsulated compounds had superior antioxidant action in comparison to their free forms (concentration range tested 1.0-25.0 µg/mL). Importantly, the formulation composed of CO and containing C and (PhSe)2 showed the highest antioxidant potential and was selected for further investigation regarding antifungal effect against some Candida spp strains. Results of in vitro antifungal assay demonstrated that the C and (PhSe)2 co-encapsulation had a minimum inhibitory concentration (MIC) values around 60. Thus, our study supplies additional data about advantages achieved by encapsulating active compounds.


Subject(s)
Benzene Derivatives/pharmacology , Candida/drug effects , Organoselenium Compounds/pharmacology , Clotrimazole/pharmacology , Nanocapsules , Antifungal Agents/pharmacology , Antioxidants/pharmacology , Microbial Sensitivity Tests
2.
Journal of Central South University(Medical Sciences) ; (12): 1305-1311, 2016.
Article in Chinese | WPRIM | ID: wpr-815093

ABSTRACT

To investigate the reversal effect of methylseleninic acid on cisplatin (DDP)-resistant ovarian cancer cells and the underlying mechanisms.
 Methods: SKOV3/DDP cells were incubated with cisplatin at different concentrations for 48 h, then the proliferation rate of SKOV3/DDP cells was detected by MTT assays, and the expression of β-catenin in SKOV3/DDP cells was examined by Western blot. The inhibitory effect of methyl-seleninic acid (MSA) combined with DDP at different concentrations on SKOV3/DDP cells was assayed by MTT method. Western blot was used to detect the expression of β-catenin protein in the cells.
 Results: The inhibitory rate for proliferation in DDP-treated SKOV3/DDP cells with different concentrations is lower than that in the SKOV3 cells (P<0.05); β-catenin expression in SKOV3/DDP cells was significantly higher than that in the SKOV3 cells (P<0.05). The inhibitory rate for proliferation in SKOV3/DDP cells with different concentrations of MSA was increased with the increase in concentration (P<0.05). The inhibitory rate for proliferation in SKOV3/DDP cells with 2 or 6 μmol/L MSA plus cisplatin was lower than that in cisplatin alone group (P<0.05). β-catenin expression in SKOV3 /DDP cells with 2 or 6 μmol/L MSA plus cisplatin was higher than that in the cisplatin alone group (P<0.05).
 Conclusion: MSA can reverse cisplatin resistance on SKOV3 / DDP cells, which may be related to the decrease in β-catenin expression.


Subject(s)
Female , Humans , Antineoplastic Agents , Pharmacology , Carcinoma , Cell Line, Tumor , Physiology , Cell Proliferation , Cisplatin , Pharmacology , Drug Resistance, Neoplasm , Genetics , Organoselenium Compounds , Pharmacology , Ovarian Neoplasms , beta Catenin , Metabolism
3.
Braz. j. med. biol. res ; 44(11): 1156-1163, Nov. 2011. ilus
Article in English | LILACS | ID: lil-604283

ABSTRACT

We evaluated the potential neuroprotective effect of 1-100 µM of four organoselenium compounds: diphenyl diselenide, 3’3-ditri-fluoromethyldiphenyl diselenide, p-methoxy-diphenyl diselenide, and p-chloro-diphenyl diselenide, against methylmercury-induced mitochondrial dysfunction and oxidative stress in mitochondrial-enriched fractions from adult Swiss mouse brain. Methylmercury (10-100 µM) significantly decreased mitochondrial activity, assessed by MTT reduction assay, in a dose-dependent manner, which occurred in parallel with increased glutathione oxidation, hydroperoxide formation (xylenol orange assay) and lipid peroxidation end-products (thiobarbituric acid reactive substances, TBARS). The co-incubation with diphenyl diselenide (100 µM) completely prevented the disruption of mitochondrial activity as well as the increase in TBARS levels caused by methylmercury. The compound 3’3-ditrifluoromethyldiphenyl diselenide provided a partial but significant protection against methylmercury-induced mitochondrial dysfunction (45.4 ± 5.8 percent inhibition of the methylmercury effect). Diphenyl diselenide showed a higher thiol peroxidase activity compared to the other three compounds. Catalase blocked methylmercury-induced TBARS, pointing to hydrogen peroxide as a vector during methylmercury toxicity in this model. This result also suggests that thiol peroxidase activity of organoselenium compounds accounts for their protective actions against methylmercury-induced oxidative stress. Our results show that diphenyl diselenide and potentially other organoselenium compounds may represent important molecules in the search for an improved therapy against the deleterious effects of methylmercury as well as other mercury compounds.


Subject(s)
Animals , Male , Mice , Brain/drug effects , Membrane Potential, Mitochondrial/drug effects , Mercury Poisoning, Nervous System/prevention & control , Methylmercury Compounds/toxicity , Mitochondria/drug effects , Neuroprotective Agents/pharmacology , Organoselenium Compounds/pharmacology , Oxidative Stress/drug effects , Analysis of Variance , Benzene Derivatives/pharmacology , Cell Fractionation , Models, Animal , Neuroprotective Agents/classification , Organoselenium Compounds/chemistry
4.
Acta Pharmaceutica Sinica ; (12): 627-631, 2010.
Article in Chinese | WPRIM | ID: wpr-354580

ABSTRACT

This study is to elucidate the metabolic pathway of 1,2-[bis (1,2-benzisoselenazolone-3 (2H)-ketone)]-ethane (BBSKE) in rats. Rats were administrated with a single dose of BBSKE 200 mg x kg(-1). The metabolites in rat urine, feces, bile and plasma were identified by LC-MSn analysis. The characterization of fragment ions from LC-MSn chromatography and mass spectrometry was applied to the investigation of structures of metabolites. Three phase I metabolites were detected in rat urine and feces. Two of them were also found in plasma and one existed in bile. These products were derived from oxidized, methylated and S-methylated BBSKE, separately. One phase II glucuronide of BBSKE was also found in bile. Therefore, it is possible that BBSKE was metabolized by oxidization, methylation and glucuronidation.


Subject(s)
Animals , Male , Rats , Administration, Oral , Antineoplastic Agents , Blood , Metabolism , Urine , Bile , Metabolism , Bridged Bicyclo Compounds, Heterocyclic , Blood , Metabolism , Urine , Chromatography, Liquid , Feces , Chemistry , Organoselenium Compounds , Blood , Metabolism , Urine , Rats, Sprague-Dawley , Spectrometry, Mass, Electrospray Ionization
5.
Biol. Res ; 42(2): 163-173, 2009. ilus, tab, graf
Article in English | LILACS | ID: lil-524886

ABSTRACT

Some selenium compounds offer important health benefits when administered at supranutritional doses, such as improvement of the immune system and of male fertility, and the prevention of some types of cancer. The traditional selenium indexes do not account for the metabolic status of this element among replete individuals. As a consequence, there is a need for new indexes that distinguish between repletion statuses of selenium. The aim of this work was to indentify some plasmatic proteins that respond to supranutritional doses of selenium, which could be proposed as new protein markers of selenium intake. The effect on rats of dietary supplementation with either selenomethylselenocysteine (SMSeC) or sodium-selenate on some blood plasma proteins was investigated. Two experimental groups consisting of six rats each were fed a basic diet supplemented with either SMSeC or sodium-selenate at 1.9 mg-Se / g-diet for ten weeks. The control group was fed a diet that contained the recommended selenium dose (0.15 mg-Se / g-diet). The changes in the abundance of a group of plasmatic proteins were quantified and analysed statistically. Haptoglobin, apolipoprotein E and transthyretin increased their abundance after diet supplementation with either form of selenium. HNF6 was responsive only to SMSeC, whereas fibrinogen responded only to sodium-selenate. We postulate that the protein patterns observed in this work could be proposed as new molecular biology-based markers of selenium intake.


Subject(s)
Animals , Male , Rats , Blood Proteins/drug effects , Cysteine/analogs & derivatives , Dietary Supplements , Organoselenium Compounds/administration & dosage , Selenium Compounds/administration & dosage , Selenium/blood , Blood Proteins/analysis , Cysteine/administration & dosage , Electrophoresis, Gel, Two-Dimensional , Mass Spectrometry , Rats, Wistar
6.
Journal of Zhejiang University. Science. B ; (12): 16-21, 2008.
Article in English | WPRIM | ID: wpr-277316

ABSTRACT

Human thioredoxin reductase (TrxR) system is associated with cancer cell growth and anti-apoptosis process. Effects of 1,2-[bis(1,2-benzisoselenazolone-3(2H)-ketone)]ethane (BBSKE), a novel TrxR inhibitor, were investigated on human leukemia cell lines HL-60 and K562. BBSKE treatment induced cell growth inhibition and apoptosis in both cell lines. Apoptosis induced by BBSKE is through Bcl-2/Bax and caspase-3 pathways. Ehrlich's ascites carcinoma-bearing mice were used to investigate the anti-tumor effect of BBSKE in vivo. Tumor-bearing mice treated with BBSKE showed an increase of life span with a comparable effect to cyclophosphamide (CTX). These results suggest a potential usage of BBSKE as a therapeutic agent against non-solid tumors.


Subject(s)
Humans , Apoptosis , Bridged Bicyclo Compounds, Heterocyclic , Pharmacology , Cell Proliferation , Enzyme Inhibitors , Pharmacology , HL-60 Cells , K562 Cells , Organoselenium Compounds , Pharmacology , Proto-Oncogene Proteins c-bcl-2 , Physiology , Thioredoxin-Disulfide Reductase , bcl-2-Associated X Protein , Physiology
7.
Iranian Journal of Nuclear Medicine. 2008; 16 (1): 25-30
in English | IMEMR | ID: emr-87073

ABSTRACT

Ubiquicidin 29-41 [UBI] is a fragment of the cationic antimicrobial peptide that is present in various species including humans. The purpose of this study was to investigate radiochemical and biological characteristics of [6-hydrazinopyridine-3-carboxylic acid [HYNIC]]-UBI 29-41 designed for the labeling with 99mTc using tricine as coligand. Synthesis was preformed on a solid phase using a standard Fmoc strategy and HYNIC precursor coupled at the N-terminus. Purified peptide conjugate was labeled with 99mTc at 100°C for 10 min. Radiochemical analysis involved ITLC and high-performance liquid chromatography methods. Peptide conjugate stability and affinity to human serum was challenged for 24 hours and its in vitro binding to bacteria was assessed. Biodistribution and accumulation of radiopeptide in staphylococcus aureus infected mice were studied using scintigraphy and ex vivo counting. Radiolabeling was performed at high specific activities, and radiochemical purity was >95%. The stability of radiolabeled peptide in human serum was excellent. In vitro studies showed 70% of radioactivity was bound to bacteria. After injection into mice with a bacterial infection, removing from the circulation occurred mainly by renal clearance and site of infection was rapidly detected within 30 min. Target to nontarget muscle ratio was 2.099 +/- 0.05% at 30 min post injection. [99mTc-HYNIC]-UBI 29-41 showed favorable radiochemical and biological characteristics which permitted detection of the infection with optimal visualization within 30 min


Subject(s)
Male , Animals, Laboratory , Organoselenium Compounds , Chromatography, High Pressure Liquid , Staphylococcus aureus , Mice
8.
Braz. j. med. biol. res ; 40(10): 1287-1304, Oct. 2007. ilus, tab
Article in English | LILACS | ID: lil-461366

ABSTRACT

The pharmacology of synthetic organoselenium compounds indicates that they can be used as antioxidants, enzyme inhibitors, neuroprotectors, anti-tumor and anti-infectious agents, and immunomodulators. In this review, we focus on the effects of diphenyl diselenide (DPDS) in various biological model organisms. DPDS possesses antioxidant activity, confirmed in several in vitro and in vivo systems, and thus has a protective effect against hepatic, renal and gastric injuries, in addition to its neuroprotective activity. The activity of the compound on the central nervous system has been studied since DPDS has lipophilic characteristics, increasing adenylyl cyclase activity and inhibiting glutamate and MK-801 binding to rat synaptic membranes. Systemic administration facilitates the formation of long-term object recognition memory in mice and has a protective effect against brain ischemia and on reserpine-induced orofacial dyskinesia in rats. On the other hand, DPDS may be toxic, mainly because of its interaction with thiol groups. In the yeast Saccharomyces cerevisiae, the molecule acts as a pro-oxidant by depleting free glutathione. Administration to mice during cadmium intoxication has the opposite effect, reducing oxidative stress in various tissues. DPDS is a potent inhibitor of d-aminolevulinate dehydratase and chronic exposure to high doses of this compound has central effects on mouse brain, as well as liver and renal toxicity. Genotoxicity of this compound has been assessed in bacteria, haploid and diploid yeast and in a tumor cell line.


Subject(s)
Animals , Mice , Rats , Antioxidants/pharmacology , Benzene Derivatives/pharmacology , Organoselenium Compounds/pharmacology , Porphobilinogen Synthase/antagonists & inhibitors , Saccharomyces cerevisiae/drug effects , Benzene Derivatives/toxicity , Models, Biological , Mutagenicity Tests , Organoselenium Compounds/toxicity
9.
Indian J Biochem Biophys ; 2007 Aug; 44(4): 257-9
Article in English | IMSEAR | ID: sea-27758

ABSTRACT

The protective role of two synthetic organoselenium compounds 1-isopropyl-3-methylbenzimidazole-2-selenone (SeI) and 1, 3-di-p-methoxybenzylpyrimidine-2-selenone (Sell) was examined against the 7,12-dimethylbenz[a]anthracene (DMBA)-induced changes in biochemical parameters in blood of rats. Albino Winstar rats (150-200 g body wt) were treated with single dose of DMBA (50 mg/kg body wt) and organoselenium compounds (25 micromol/kg) for 4 weeks at two days internal. Blood was taken from the anaesthetized rats ventricle from their hearts for biochemical analysis. Administration of DMBA resulted in elevation of urea, uric acid and creatinine levels as well as AST, ALT and LDH activities and decrease in levels of total proteins, albumin and globulin. SeI and SeII caused a significant (p<0.05) decrease in urea, uric acid and creatinine levels and alanine aminotransferase (ALT); aspartate aminotransferase; (AST) and lactate dehydrogenase (LDH) activities and significantly increased the levels of total protein and albumin (p<0.05). These organoselenium compounds are likely to be beneficial in human health.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Benzimidazoles/pharmacology , Blood Proteins/analysis , Carcinogens/toxicity , Environmental Pollutants/toxicity , Enzymes/blood , Lipid Peroxidation/drug effects , Organoselenium Compounds/pharmacology , Pyrimidines/pharmacology , Rats , Rats, Wistar
10.
JAMC-Journal of Ayub Medical College-Abbotabad-Pakistan. 2007; 19 (2): 42-45
in English | IMEMR | ID: emr-94130

ABSTRACT

Gated Single Photon Emission Computerized Tomography [SPECT] is a modality which is helpful in the detection of wall motion, thickening and ejection fraction of left ventricle. The purpose of this study was to correlate the ungated and gated SPECT in evaluation of left ventricle dysfunction. It was a prospective study done at Institute of Radiotherapy and Nuclear Medicine [IRNUM], Peshawar, in 2001/02. 76 patients [47 male and 29 female] with an average age of 52 +/- 11 years were inducted in this study. All patients underwent two days stress-rest Tc-99m MIBI [Methoxy Isobutyl Isonitrile] gated SPECT scan where 1110 MBq [30 mCi] was injected intravenously. Eight frames gating technique [variable fixed temporal resolution] of ECG was used to gate the cardiac cycle and whole acquisition was completed in 30 minutes. This technique very well evaluated the perfusion as well as wall motion/thickening [W/M/T] status of left ventricle. Out of 76 scans, 30% were normal, 22% transmural infarct, 25% partial thickness infarct, and 22% reversible ischemia. By doing the 20 segmental analyses, total 1520 segments were analyzed that


evealed good concordance of perfusion with W/M/T in 78% of segments while 22% segments showed poor concordance. Out of these 22%, 12% were having more wall motion abnormalities than that of perfusion, while in 10%, it was vise versa. Results of this study shows good correlation between gated and ungated SPECT for evaluation of left ventricle dysfunction [r = 0.73, p

Subject(s)
Humans , Male , Female , Myocardial Perfusion Imaging , Heart Ventricles/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Radionuclide Ventriculography , Myocardial Ischemia , Organoselenium Compounds , Prospective Studies
11.
Acta Pharmaceutica Sinica ; (12): 1184-1187, 2006.
Article in Chinese | WPRIM | ID: wpr-281963

ABSTRACT

<p><b>AIM</b>To synthesize the selenophosphocholine analogues containing tegafur and test their antitumor activities.</p><p><b>METHODS</b>The cyclic glyceroselenophospholopid conjugate of tegafur was synthesized by the reaction of hexaethylphosphorous triamide with N1-(2-furanidyl)-N3-(hydroxyalkyl)-5-fluyorouracil and 1-O-hexadecyl glycerol as well as selenium in one-pot. Cyclic glyceroselenophospholopid conjugate of tegafur reacted with triethylamine to give title compounds.</p><p><b>RESULTS</b>Six new compounds have been synthesized. Their structures were confirmed by 1H NMR, 13P NMR and elemental analysis. Antitumor activity of the title compounds against PGA1 was tested.</p><p><b>CONCLUSION</b>The reaction of triethylamine with cyclic glyceroselenophospholopid conjugate of tegafur very readily occurred, which was finished within 2 h at room temperature. The opening-ring products of trans isomers showed antimutor activity against human uriaryl bladder cancer cell more effective than that of the tegafur.</p>


Subject(s)
Humans , Antineoplastic Agents , Pharmacology , Cell Line, Tumor , Magnetic Resonance Spectroscopy , Organoselenium Compounds , Pharmacology , Phosphorylcholine , Tegafur , Pharmacology , Urinary Bladder Neoplasms , Drug Therapy , Pathology
12.
Journal of Zhejiang University. Science. B ; (12): 393-396, 2006.
Article in English | WPRIM | ID: wpr-251909

ABSTRACT

A simple and convenient procedure for stereoselective synthesis of (Z)-allyl selenides has been developed by a one-pot reaction of diselenides with Baylis-Hillman adducts in the presence of samarium metal-trimethylsilyl chloride under mild conditions. Presumably, the diselenides are cleaved by Sm/TMSCl system to form selenide anions, which then undergo S(N)2' substitution of Baylis-Hillman adducts to produce the (Z)-allyl selenides.


Subject(s)
Magnetic Resonance Spectroscopy , Molecular Structure , Organoselenium Compounds , Chemistry , Selenium Compounds , Chemistry , Stereoisomerism
13.
Chinese Journal of Preventive Medicine ; (12): 324-327, 2005.
Article in Chinese | WPRIM | ID: wpr-282338

ABSTRACT

<p><b>OBJECTIVE</b>To assess how trace element selenium and B27 supplements affect the neural stem cell (NSc) differentiation in vitro.</p><p><b>METHODS</b>The development and differentiation of NSc from the newborn rat were observed with primary culture and subculture during treating by sodium-selenite, and selenium-methyl-cysteine (SMC). The immunocytochemistry techniques were used to identify the NSc and mature protein expression with neuron marker beta-tubulin, astrocyte marker GFAP, and oligodendrocyte marker CNPase. The neurosphere morphology and neurite outgrowth were observed.</p><p><b>RESULTS</b>Adding the complete B-27 serum-free supplement, Selenium could promote the neurosphere viability, development and differentiation. Without selenium and B-27, neurosphere could not survive and differentiate. Without B-27 in the medium but there containing selenium, the neurosphere could promote the viability and development into neuron, astrocyte and oligodendrocyte, as compared with the no-containing B-27 and selenium groups, these differentiated cells might have more quantity, more branches and better morphological nerve net. The count of the neuron, astrocyte and oligodendrocyte was 11.2/Hp, 16.1/Hp and 9.3/Hp.</p><p><b>CONCLUSIONS</b>The selenium should be very important for neural stem cells' survival. Selenium could promote the neurosphere cells differentiation and development.</p>


Subject(s)
Animals , Female , Male , Rats , Animals, Newborn , Cell Differentiation , Cell Survival , Cells, Cultured , Culture Media, Serum-Free , Pharmacology , Cysteine , Pharmacology , Glial Fibrillary Acidic Protein , Metabolism , Immunohistochemistry , Neurons , Cell Biology , Metabolism , Organoselenium Compounds , Pharmacology , Rats, Wistar , Selenium , Pharmacology , Selenocysteine , Sodium Selenite , Pharmacology , Stem Cells , Cell Biology , Metabolism , Tubulin , Metabolism
14.
Braz. j. med. biol. res ; 35(6): 623-631, June 2002. ilus
Article in English | LILACS | ID: lil-309507

ABSTRACT

The interaction of the product of H2O2 and (PhSe)2 with delta-aminolevulinate dehydratase (delta-ALA-D) from mammals and plants was investigated. (PhSe)2 inhibited rat hepatic delta-ALA-D with an IC50 of 10 æM but not the enzyme from cucumber leaves. The reaction of (PhSe)2 with H2O2 for 1 h increased the inhibitory potency of the original compound and the IC50 for animal delta-ALA-D inhibition was decreased from 10 to 2 æM. delta-ALA-D from cucumber leaves was also inhibited by the products of reaction of (PhSe)2 with H2O2 with an IC50 of 4 æM. The major product of reaction of (PhSe)2 with H2O2 was identified as seleninic acid and produced an intermediate with a lambdamax at 265 nm after reaction with t-BuSH. These results suggest that the interaction of (PhSe)2 with mammal delta-ALA-D requires the presence of cysteinyl residues in close proximity. Two cysteine residues in spatial proximity have been recently described for the mammalian enzyme. Analysis of the primary structure of plant delta-ALA-D did not reveal an analogous site. In contrast to (PhSe)2, seleninic acid, as a result of the higher electrophilic nature of its selenium atom, may react with additional cysteinyl residue(s) in mammalian delta-ALA-D and also with cysteinyl residues from cucumber leaves located at a site distinct from that found at the B and A sites in mammals. Although the interaction of organochalcogens with H2O2 may have some antioxidant properties, the formation of seleninic acid as a product of this reaction may increase the toxicity of organic chalcogens such as (PhSe)2


Subject(s)
Animals , Cattle , Rats , Cucumis sativus , Hydrogen Peroxide , Liver , Organoselenium Compounds , Porphobilinogen Synthase , Analysis of Variance
SELECTION OF CITATIONS
SEARCH DETAIL